Related Experiment Video
Updated: Aug 26, 2026
Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
The potential for QT prolongation by antiepileptic drugs in children
Soonhak Kwon1, Sangbum Lee, Myungchul Hyun
1Department of Pediatrics, Kyungpook National University Hospital, Joong-gu, Daegu, South Korea.
Insights
Antiepileptic drugs may not cause QT prolongation in children with epilepsy, a potential cause of sudden unexpected death. Further research is needed to confirm these findings in pediatric epilepsy patients.
Area of Science:
- Pediatric Cardiology
- Neurology
- Clinical Pharmacology
Background:
- Sudden unexpected death in epilepsy (SUDEP) is a concern in pediatric patients.
- Cardiac arrhythmia, specifically QT prolongation, is a suspected contributor to SUDEP.
- The role of antiepileptic drugs (AEDs) in inducing QT prolongation in children with epilepsy requires investigation.
Purpose of the Study:
- To assess drug-induced QT prolongation in children with epilepsy.
- To determine if AED use contributes to QT prolongation and potentially SUDEP.
- To compare QT intervals in children with epilepsy on AEDs versus drug-free controls.
Main Methods:
- A study involving 178 children with epilepsy and 26 age-matched controls.
- Manual measurement and Fridericia's correction (QTFc) for QT intervals.
- Analysis of QT intervals in children on monotherapy (valproate, carbamazepine/oxcarbazepine, topiramate) and polytherapy, compared to controls.
Main Results:
- Mean corrected QT intervals (QTc) were similar between children with epilepsy on AEDs (0.40 +/- 0.03 s) and drug-free controls (0.40 +/- 0.03 s).
- No statistically significant differences in QTc were found among different AED monotherapy groups (valproate, carbamazepine/oxcarbazepine, topiramate).
- No significant difference in QTc was observed between monotherapy (0.40 +/- 0.02 s) and polytherapy (0.39 +/- 0.03 s) groups.
Conclusions:
- Major antiepileptic drugs do not appear to precipitate significant QT interval prolongation in children with epilepsy.
- The findings suggest AEDs may not be a primary driver of QT prolongation linked to SUDEP in this population.
- Further studies are warranted to definitively establish the relationship between AEDs, QT intervals, and SUDEP in pediatric epilepsy.
Abstract:
Cardiac arrhythmia may be one of the major causes of sudden unexpected death in children with epilepsy. We assessed drug-induced QT prolongation to establish whether the use of antiepileptic drugs contributes to sudden unexpected death. A total of 178 children with epilepsy (93 males and 85 females, with ages ranging from 1 month to 18.9 years; mean age 7.0 +/- 4.1 years) were involved in the study. The QT intervals were manually measured and corrected using Fridericia's formula (QTFc = QT/RR(1/3)). The mean corrected QT interval (QTc) of 152 children on antiepileptic drugs during the study period was 0.40 +/- 0.03 s, and for 26 age-matched, antiepileptic drug-free control patients it was 0.40 +/- 0.03 s. The mean QTc of the children with monotherapy was 0.40 +/- 0.03 s for the valproate group (n = 42), 0.39 +/- 0.02 s for the carbamazepine/oxcarbazepine group (n = 34), and 0.40 +/- 0.02 s for the topiramate group (n = 26), respectively. There was no statistically significant difference among the groups as assessed by analysis of variance. In addition, there was no significant difference between the monotherapy group (n = 109; 0.40 +/- 0.02 s) and the polytherapy group (n = 43; 0.39 +/- 0.03 s). Major antiepileptic drugs may not precipitate prolongation of the QT interval into sudden unexpected death in children with epilepsy, however further studies are required.
Related Concept Videos
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
01:08Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion